pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Vykat XR
drug
save

diazoxide choline ER

Marketedupdated 3mo ago
by $SLNO SOLENO THERAPEUTICS INC
Approved
community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying diazoxide choline ER

  • —Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndromeenrolling by invitationn=200

Patent cliff

source: FDA Orange Book
first barrier falls
Dec 20, 2026
127 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (18)

  • Nov 12, 2035method-of-use (U-4167)US 12178823
  • Nov 12, 2035method-of-use (U-4167)US 12178823
  • Nov 12, 2035method-of-use (U-4167)US 12178823
  • Nov 12, 2035method-of-use (U-4211)US 12343348
  • Nov 12, 2035method-of-use (U-4211)US 12343348
  • Nov 12, 2035method-of-use (U-4211)US 12343348
  • Nov 12, 2035method-of-use (U-4275)US 12419895
  • Nov 12, 2035method-of-use (U-4275)US 12419895
  • Nov 12, 2035method-of-use (U-4275)US 12419895
  • Nov 12, 2035method-of-use (U-4167)US 9757384
  • Nov 12, 2035method-of-use (U-4167)US 9757384
  • Nov 12, 2035method-of-use (U-4167)US 9757384
  • Mar 5, 2029compositionUS 77997772.6y
  • Mar 5, 2029compositionUS 77997772.6y
  • Mar 5, 2029compositionUS 77997772.6y
  • Dec 20, 2026compositionUS 7572789127d
  • Dec 20, 2026compositionUS 7572789127d
  • Dec 20, 2026compositionUS 7572789127d

FDA exclusivities (3)

  • Mar 26, 2028NPNP1.6y
  • Mar 26, 2028NPNP1.6y
  • Mar 26, 2028NPNP1.6y

News(5)

  • Four questions on new safety warnings for Neurocrine’s Vykat XR
    A group of experts on Prader-Willi syndrome has sounded the alarm on side effects and deaths that may be connected to Neurocrine Biosciences’ medicine Vykat XR. The treatment has been linked to sev…
    endpoints · 2d ago
  • Deaths reported after treatment with Neurocrine’s approved Prader-Willi drug
    Reports of seven deaths in patients who had taken Neurocrine Biosciences’ Vykat and the official termination of Aardvark Therapeutics’ Phase 3 trial after cardiac complications marked a tough day f…
    biospace · 2d ago
  • STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and more
    Eli Lilly filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutide
    stat · 2d ago
  • STAT+: Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say
    A newly approved drug for Prader-Willi syndrome, a rare disease that causes an insatiable desire to eat, may be tied to a series of patient deaths, experts say.
    stat · 2d ago
  • Novo’s late-stage IL-6 stumble shakes inflammation space
    Novo Nordisk was banking on the inflammatory benefits of its investigational therapy ziltivekimab to improve cardiovascular outcomes. Last week’s Phase 3 failure dashed not just the Danish pharma’s…
    biospace · 11d ago
brand
Vykat XR
generic
diazoxide choline
indication
Prader-Willi Syndrome (PWS)
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 27m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?